Results for tag: "Aprepitant"

Aprepitant is a drug used to treat nausea and vomiting caused by chemotherapy and radiation therapy. It is a member of the class of drugs known as neurokinin-1 (NK-1) receptor antagonists, which work by blocking the action of a chemical messenger in the brain that causes nausea and vomiting. Aprepitant is also used to prevent nausea and vomiting caused by surgery. It is available in both oral and intravenous formulations. Aprepitant is used in combination with other antiemetic drugs to provide more effective relief from nausea and vomiting. It is also used in combination with other drugs to treat irritable bowel syndrome (IBS). Aprepitant is generally well tolerated, with few side effects. The aprepitant market is a growing segment of the gastrointestinal drugs market. It is used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy and radiation therapy, as well as irritable bowel syndrome. Aprepitant is available in both oral and intravenous formulations, and is generally well tolerated with few side effects. Some companies in the aprepitant market include Merck & Co., Inc., Pfizer, Inc., and GlaxoSmithKline plc. Show Less Read more